Enzalutamide Could Have Pivotal Role in Metastatic Hormone-Sensitive Prostate Cancer
Christopher Sweeney, MBBS, discusses the results of the ENZAMET trial and the next steps for researching the efficacy of enzalutamide in the treatment of patients with metastatic hormone-sensitive prostate cancer.
Source: OncLive